Form 485BPOS LAZARD FUNDS INC
Securities Act File No. 33-40682
Investment Company Act File No. 811-06312
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-1A
| REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 | x | ||
| Post-Effective Amendment No. 140 | x | ||
| and | |||
| REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 | x | ||
| Amendment No. 140 | x | ||
(Check appropriate box or boxes)
THE LAZARD FUNDS, INC.
(Exact Name of Registrant as Specified in Charter)
(212) 632-6000
(Registrant’s Telephone Number, including Area Code)
30 Rockefeller Plaza, New York, New York 10112
(Address of Principal Executive: Number, Street, City, State, Zip Code)
Mark R. Anderson, Esq.
30 Rockefeller Plaza
New York, New York 10112
(Name and Address of Agent for Services)
Copy to:
Janna Manes, Esq.
Proskauer Rose LLP
Eleven Times Square
New York, New York 10036
It is proposed that this filing will become effective (check appropriate box)
| x | immediately upon filing pursuant to paragraph (b) |
| o | on (DATE) pursuant to paragraph (b) |
| o | 60 days after filing pursuant to paragraph (a)(1) |
| o | on (DATE) pursuant to paragraph (a)(1) |
| o | 75 days after filing pursuant to paragraph (a)(2) |
| o | on (DATE) pursuant to paragraph (a)(2) of Rule 485. |
| If appropriate, check the following box: | |
| o | this post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all of the requirements for effectiveness of this Amendment to the Registration Statement under Rule 485(b) of the Securities Act of 1933 and has duly caused this Amendment to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, and State of New York, on the 2nd day of July, 2020.
| THE LAZARD FUNDS, INC. | |||
| By: | /s/ Nathan A. Paul* | ||
| Nathan A. Paul, Chief Executive Officer | |||
Pursuant to the requirements of the Securities Act of 1933, this Amendment to Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
| /s/ Nathan A. Paul* | President and Director | July 2, 2020 |
| Nathan A. Paul | ||
| /s/ Christopher Snively* | Chief Financial Officer | July 2, 2020 |
| Christopher Snively | ||
| /s/ Ashish Bhutani* | Director | July 2, 2020 |
| Ashish Bhutani | ||
| /s/ Franci J. Blassberg* | Director | July 2, 2020 |
| Franci J. Blassberg | ||
| /s/ Kenneth S. Davidson* | Director | July 2, 2020 |
| Kenneth S. Davidson | ||
| /s/ Nancy A. Eckl* | Director | July 2, 2020 |
| Nancy A. Eckl | ||
| /s/ Trevor W. Morrison* | Director | July 2, 2020 |
| Trevor W. Morrison | ||
| /s/ Richard Reiss, Jr.* | Director | July 2, 2020 |
| Richard Reiss, Jr. | ||
| /s/ Robert M. Solmson* | Director | July 2, 2020 |
| Robert M. Solmson | ||
| *By: | /s/ Shari L. Soloway | |
| Attorney-in-fact, Shari L. Soloway |
EXHIBIT INDEX
| Exhibit No. | Description |
| EX-101.INS | XBRL Instance Document |
| EX-101.SCH | XBRL Taxonomy Extension Schema Document |
| EX-101.DEF | XBRL Taxonomy Extension Definition Linkbase |
| EX-101.LAB | XBRL Taxonomy Extension Labels Linkbase |
| EX-101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chiesi Group completes KalVista acquisition for $27 per share
- Lazard reports May assets under management at $284.8 billion
- Incyte to acquire Vega Therapeutics for $1.25 billion upfront
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share